McColm, Juliet <br/><br/>
Evaluation of single and multiple doses of a novel mGlu2 agonist, a potential antipsychotic therapy, in healthy subjects.  [electronic resource] 

 -  British journal of clinical pharmacology  08 2017 
 - 1654-1667 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2125 
<br/><br/><label>Standard No.: </label>10.1111/bcp.13252  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Area Under Curve<br/>Bridged Bicyclo Compounds--blood<br/>Cohort Studies<br/>Disorders of Excessive Somnolence--chemically induced<br/>Dizziness--chemically induced<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Half-Life<br/>Headache<br/>Healthy Volunteers<br/>Humans<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Placebos<br/>Prodrugs--pharmacology<br/>Receptors, Metabotropic Glutamate--agonists<br/>Triazoles--blood<br/>Vomiting--chemically induced<br/>Young Adult